Page last updated: 2024-10-20

pyridoxamine and Left Ventricular Hypertrophy

pyridoxamine has been researched along with Left Ventricular Hypertrophy in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, ET1
Liang, JT1
Wu, MS1
Chang, KC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Serum Levels of Advanced Glycation End-products After Dietary Intervention in Hypertensive Patients: Study Protocol of a Randomized Clinical Trial.[NCT02848677]Phase 2120 participants (Anticipated)Interventional2015-11-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for pyridoxamine and Left Ventricular Hypertrophy

ArticleYear
Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation.
    Experimental gerontology, 2011, Volume: 46, Issue:6

    Topics: Aging; Animals; Aorta; Atherosclerosis; Body Weight; Collagen; Elasticity; Hypertrophy, Left Ventric

2011